← All trials
NCT04846439
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 29, 2021
- Primary completion
- Mar 31, 2023
- Completion date
- Mar 31, 2024
- First posted
- Apr 15, 2021
- Last posted
- Oct 27, 2021
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Soochow UniversityLead sponsor
- Soochow UniversityOverall official - principal investigator
- Nanjing Medical UniversityCollaborator
- Nanjing UniversityCollaborator
- Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdCollaborator
- Huai'an Second People's HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.